These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17101577)

  • 1. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes.
    Bruha R; Vitek L; Petrtyl J; Lenicek M; Urbanek P; Zelenka J; Jachymova M; Svestka T; Kalab M; Dousa M; Marecek Z
    Scand J Gastroenterol; 2006 Dec; 41(12):1454-63. PubMed ID: 17101577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol or propranolol in portal hypertension? A randomized comparison.
    Hobolth L; Møller S; Grønbæk H; Roelsgaard K; Bendtsen F; Feldager Hansen E
    Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
    Sekiyama T; Komeichi H; Nagano T; Ohsuga M; Terada H; Katsuta Y; Satomura K; Aramaki T
    Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
    Fierbinteanu-Braticevici C; Udeanu M; Dragomir P; Andronescu D
    Rom J Intern Med; 2003; 41(3):247-54. PubMed ID: 15526508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.
    De BK; Das D; Sen S; Biswas PK; Mandal SK; Majumdar D; Maity AK
    J Gastroenterol Hepatol; 2002 Feb; 17(2):183-9. PubMed ID: 11966949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
    Kim SG; Kim TY; Sohn JH; Um SH; Seo YS; Baik SK; Kim MY; Jang JY; Jeong SW; Lee B; Kim YS; Suk KT; Kim DJ
    Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
    Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M;
    J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carvedilol on portal pressure estimated by hepatic vein Doppler ultrasound waveform and damping index in cirrhotic patients.
    Hussain Q; Badruddin AH; Chaudhry MA; Ahmad F; Abbasi A
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):586-9. PubMed ID: 20810049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis.
    Aguilar-Olivos N; Motola-Kuba M; Candia R; Arrese M; Méndez-Sánchez N; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2014; 13(4):420-8. PubMed ID: 24927613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients.
    Buck M; Garcia-Tsao G; Groszmann RJ; Stalling C; Grace ND; Burroughs AK; Patch D; Matloff DS; Clopton P; Chojkier M
    Hepatology; 2014 Mar; 59(3):1052-9. PubMed ID: 24115225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.